咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >An essential role for TAK1 in ... 收藏

An essential role for TAK1 in the contact hypersensitivity response

作     者:Yan G Zhao Yunqi Wang Weidong Hao Yisong Y Wan 

作者机构:Department of ToxicologySchool of Public HealthPeking UniversityBeijingChina Department of Microbiology and ImmunologyLineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel HillNCUSA 

出 版 物:《Cellular & Molecular Immunology》 (中国免疫学杂志(英文版))

年 卷 期:2011年第8卷第4期

页      面:315-324页

核心收录:

学科分类:0710[理学-生物学] 071001[理学-植物学] 07[理学] 

基  金:the National Institutes of Health(R00AI072956 to YYW) the Beijing Natural Science Foundation(7082054) the National Science and Technology Major Specific Project of the People’s Republic of China(2009ZX09301-010 to WH)and the China Scholarship Council(YGZ) 

主  题:CHS DC 2,4-dinitrofluorobenzene(DNFB) TAK1 

摘      要:Contact hypersensitivity(CHS)is a delayed-type hypersensitivity that can be induced by haptens,such as 2,4-dinitrofluorobenzene(DNFB).Innate and adaptive immunities are both important for the development of *** treat CHS-related diseases,such as allergic contact dermatitis,a disease prevalent in industrialized countries,ways of interfering with improper immune function during CHS responses need to be *** growth factor-b-activated kinase-1(TAK1),a member of mitogen-activated protein kinase kinase kinase family,is important for both innate and adaptive *** thus hypothesized that the CHS response could be inhibited by interfering with TAK1 *** a mouse model in which TAK1 deletion can be locally induced,we observed that TAK deficiency led to an impaired CHS response and was associated with defective T-cell expansion,activation and interferon(IFN)-c *** addition,we investigated the effect of deleting TAK1 specifically in dendritic cells(DC)on the CHS *** found that when TAK1 is deficient in DC,the CHS response was abolished and hapten-elicited T-cell responses were ***,this study demonstrates an essential role of TAK1 in the induction of CHS and suggests that targeting TAK1 could be a viable approach to treat CHS.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分